EQUIPIN Drug Patent Profile
✉ Email this page to a colleague
When do Equipin patents expire, and when can generic versions of Equipin launch?
Equipin is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in EQUIPIN is homatropine methylbromide. There are five drug master file entries for this compound. Additional details are available on the homatropine methylbromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EQUIPIN?
- What are the global sales for EQUIPIN?
- What is Average Wholesale Price for EQUIPIN?
Summary for EQUIPIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Patent Applications: | 2 |
| DailyMed Link: | EQUIPIN at DailyMed |
US Patents and Regulatory Information for EQUIPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | EQUIPIN | homatropine methylbromide | TABLET, CHEWABLE;ORAL | 086310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
